MOTS-C: Mitochondrial-Derived Peptide Research Guide MOTS-C is a short peptide encoded within mitochondrial DNA
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Gut symptoms may involve motility, inflammation, infection, immune reactions, microbiome changes, or medication effects
For visible skin-support routines, consistency matters more than applying too much at once
Check all these before you place your next research-use-only order
Better safe than sorry, right